Overview
- Description
The company develops innovative bioresorbable tissue-engineering implants, specializing in breast and skin reconstruction solutions that naturally regenerate tissue.
- Website
- Country
- France
- Sector
- Medical Technologies
“The EIC Fund process for our series A was a real opportunity to share, discuss and build a roadmap with our lead investors in the next steps of Lattice Medical. The process is fluid, the person chosen for the due diligence was smart with good questions and interrogations and we have concluded the deal in 8 months.”
Julien Payen, CEO
